Bli medlem
Bli medlem

Du är här


Scandinavian ChemoTech has secured CE-marked electrodes for deep-seated tumours

Following successful final tests Scandinavian ChemoTech, along with its partner in electrode technology, has developed CE-marked treatment kits for deep-seated tumours.

The Company's new treatment kits are primarily developed for the treatment of deep-seated tumours. These have now passed the important compatibility tests between the new electrodes and our TSE™ technology. These new kits are intended for use in both human and veterinary medicine.

"It feels very good to have been able to secure access to CE-marked treatment kits even for deep-seated tumours. This enables us to now begin clinical trials on these kinds of tumours, which in significant ways may change the conditions for both ChemoTech and Vetiqure." - says Mohan Frick, CEO Scandinavian ChemoTech

This disclosure contains information that ChemoTech is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 25-10-2021 09:30 CET.

For more information, please contact:

Mohan Frick, CEO

Phone: +46 (0)10-218 93 00

Certified Adviser: Erik Penser Bank, Tel: +46 8 463 80 00, E-mail:

Författare Cision